How Many Injections Are in a Mounjaro Pen?

Last reviewed: July 13, 2026

Last updated: July 13, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Mounjaro pens are pre-filled injection devices designed to deliver tirzepatide, a dual GLP-1 and GIP receptor agonist approved for weight loss and diabetes management. Each Mounjaro pen holds exactly four injections at a fixed dose level, meaning patients typically need multiple pens across their treatment journey as their dose escalates.

Mounjaro Pen Injection Count and Design

Each Mounjaro pen contains four single-dose injections that cannot be divided or adjusted. The pen is color-coded by dose strength, ranging from the lowest starting dose to higher maintenance doses. Once a patient completes all four injections from one pen, they must obtain a new pen at their next dose level.

The pre-filled cartridge system simplifies administration for patients who prefer auto-injectors over vials. However, this design means a patient starting at the lowest dose will need to purchase four separate pens before reaching a typical maintenance dose, as the standard protocol involves weekly injections for four weeks at each level before escalation.

Understanding the Tirzepatide Dosing Sequence

Tirzepatide dosing follows a structured titration schedule where patients begin at the lowest concentration and gradually increase weekly. The typical progression moves from the starter dose through intermediate levels, with each level lasting four weeks—the exact duration of one Mounjaro pen's supply.

This step-wise approach allows the body to adjust to the medication while monitoring for side effects and tolerance. Patients who reach their therapeutic dose may stay at that level for months or longer, potentially requiring multiple pens of the same strength during maintenance therapy.

Cost Implications of Multi-Pen Treatment Plans

The four-injection pen structure affects overall treatment cost when using brand-name Mounjaro, since patients must purchase complete pens even if they need only partial supplies during dose transitions. A typical titration sequence requires four to five pens before reaching a stable maintenance dose, creating significant upfront expenses for many patients.

PlexusDx offers compounded tirzepatide injection as an alternative, priced at a flat $289/mo (or $249/mo on the 6-month plan) regardless of dose level. This pricing model eliminates the need to purchase multiple pens for titration—patients pay one consistent monthly rate whether they're starting or maintaining their therapy, with the clinical flexibility to adjust doses as their body responds.

Comparing Pen-Based and Compounded Tirzepatide Options

Brand-name Mounjaro pens require patients to manage inventory across multiple strengths and pay separately for each pen purchase. Compounded tirzepatide from licensed 503A pharmacies offers the same active ingredient but in customizable doses delivered through vials that allow precise titration without purchasing excess medication.

PlexusDx tirzepatide injections are $289/mo month-to-month, or from $249/mo on the 6-month plan with no price changes as dose increases—meaning titration costs remain transparent and predictable. All medications are produced in licensed 503A compounding pharmacies and are available across all 50 states without insurance or membership fees, with HSA and FSA eligibility included.

Genetic Testing for Personalized Tirzepatide Response

Individual differences in how tirzepatide works depend partly on genetic variants affecting GLP-1 and GIP receptor function. PlexusDx Precision Peptide Genetic Test identifies key genetic markers including GLP1R rs6923761 and GIPR rs1800437 that influence how efficiently your body responds to tirzepatide therapy.

This genetic insight helps guide treatment decisions during the titration phase, potentially reducing the number of dose adjustments needed and optimizing outcomes faster. The test maps 14 peptide pathways across 150+ genetic insights, offering personalized data that complements standard clinical dosing protocols.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How many injections do I get in one Mounjaro pen?

A single Mounjaro pen contains exactly four pre-filled injections, each at the same dose strength. Since tirzepatide is injected once weekly, one pen supplies a four-week treatment cycle.

Why does my prescription require multiple pens during treatment?

Tirzepatide follows a titration protocol where the dose increases weekly for four weeks, then stays constant. Each dose strength comes in a separate pen, so reaching maintenance therapy typically requires four to five different pens as you progress through dose levels.

How much does compounded tirzepatide cost at PlexusDx?

PlexusDx compounded tirzepatide injection is $289/mo month-to-month (or $249/mo on the 6-month plan) with a flat-rate pricing model—your dose may need to go up, but your price won't. No insurance is required, and the medication is HSA and FSA eligible.

What's the difference between Mounjaro pens and compounded tirzepatide?

Both contain the same active ingredient, but compounded tirzepatide from PlexusDx offers dosing flexibility without purchasing separate pens at each strength. You receive a month's supply in a vial at your prescribed concentration, simplifying titration and reducing costs.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

Yes. PlexusDx Precision Peptide Genetic Test identifies variants in GLP1R and GIPR genes that influence how your body responds to tirzepatide. This personalized insight helps optimize your starting dose and titration pace for faster, more effective results.

Is PlexusDx tirzepatide FDA-approved?

PlexusDx tirzepatide is compounded at licensed 503A pharmacies using FDA-approved tirzepatide powder. Compounded medications are not individually FDA-approved but are prepared under strict pharmaceutical standards.

Related Reading

• Mounjaro Injections
• Weight Loss Injections Mounjaro
• Hers Mounjaro
• Hims Mounjaro

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.